{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-000517","form_type":"8-K","ticker":"PAVM","cik":"0001624326","company_name":"PAVmed Inc.","filed_at":"2025-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.225140+00:00","generated_at":"2026-05-24T05:48:19.728876+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"PAVmed reports Q4 net income $1.3M; Lucid record tests, Veris financing, debt restructured","bullets":["GAAP net income $1.3M ($0.12 diluted EPS); non-GAAP adjusted loss $0.7M ($0.06) per share.","Lucid processed 4,042 EsoGuard tests in Q4 (+84% YoY); secured first insurance coverage from Highmark Blue Cross Blue Shield.","Veris closed ~$2.4M private placement at $35M pre-money valuation to advance implantable monitor toward FDA clearance.","PAVmed cash $1.2M at Dec 31; pro forma $3.6M including Q1 2025 private placement.","Deconsolidation of Lucid and convertible debt restructuring added ~$25M to equity, regaining Nasdaq minimum equity compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-000517","json":"https://secwatch.observer/filing/0001641172-25-000517.json","markdown":"https://secwatch.observer/filing/0001641172-25-000517.md","text":"https://secwatch.observer/filing/0001641172-25-000517.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1624326/000164117225000517/0001641172-25-000517-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1624326/000164117225000517/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T05:48:19.728876+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}